WAM
BIO icon

World Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

World Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$269K Sell
360
-43
-11% -$32.2K 0.03% 682
2021
Q2 		$260K Sell
403
-14
-3% -$8.52K 0.02% 739
2021
Q1 		$263K Sell
417
-37
-8% -$21.9K 0.02% 741
2020
Q4 		$265K Sell
454
-1
-0.2% -$570 0.03% 700
2020
Q3 		$235K Buy
455
+4
+0.9% +$2.03K 0.02% 670
2020
Q2 		$204K Buy
+451
New +$199K 0.02% 704
2020
Q1 		– Sell
-574
Closed -$212K – 961
2019
Q4 		$212K Sell
574
-120
-17% -$42.3K 0.01% 960
2019
Q3 		$231K Buy
694
+31
+5% +$10.1K 0.01% 960
2019
Q2 		$207K Sell
663
-6
-0.9% -$1.8K 0.01% 1040
2019
Q1 		$204K Buy
+669
New +$181K 0.01% 1055
2018
Q4 		– Sell
-742
Closed -$232K – 1115
2018
Q3 		$232K Buy
742
+4
+0.5% +$1.24K 0.01% 1075
2018
Q2 		$213K Buy
+738
New +$204K 0.01% 1146
2018
Q1 		– Sell
-937
Closed -$224K – 1371
2017
Q4 		$224K Sell
937
-85
-8% -$20.6K 0.01% 1310
2017
Q3 		$227K Sell
1,022
-3
-0.3% -$675 0.01% 1303
2017
Q2 		$232K Buy
1,025
+14
+1% +$3.05K 0.01% 1271
2017
Q1 		$202K Buy
+1,011
New +$195K 0.01% 1289
2016
Q4 		– Sell
-1,347
Closed -$221K – 1377
2016
Q3 		$221K Buy
+1,347
New +$204K 0.01% 1201
2015
Q2 		– Sell
-1,620
Closed -$219K – 1159
2015
Q1 		$219K Buy
+1,620
New +$201K 0.01% 1233
2014
Q4 		– Sell
-1,867
Closed -$212K – 1418
2014
Q3 		$212K Sell
1,867
-24
-1% -$2.84K 0.01% 1304
2014
Q2 		$226K Sell
1,891
-84
-4% -$10.3K 0.01% 1330
2014
Q1 		$253K Sell
1,975
-2
-0.1% -$256 0.01% 1257
2013
Q4 		$244K Sell
1,977
-325
-14% -$39.6K 0.01% 1290
2013
Q3 		$271K Sell
2,302
-401
-15% -$47.3K 0.01% 1346
2013
Q2 		$303K Buy
+2,703
New +$317K 0.01% 1312

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

World Asset Management's BIO Position: Q3 2021 in Review

World Asset Management reduced its Bio-Rad Laboratories Class A (BIO) stake by 11% in Q3 2021, selling an estimated $32.2K and leaving 360 shares worth $269K. The position accounts for 0.03% of the portfolio, ranked #682.

World Asset Management first reported a position in BIO in Q2 2013 and has held it in 24 quarters since. The position peaked at $303K in Q2 2013. 508 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

  • World Asset Management held 360 shares of Bio-Rad Laboratories Class A worth $269K as of Q3 2021.
  • World Asset Management sold 43 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $32.2K.
  • Bio-Rad Laboratories Class A made up 0.03% of World Asset Management's portfolio in Q3 2021, its #682 holding.
  • World Asset Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 24 quarters since.
  • World Asset Management's Bio-Rad Laboratories Class A position peaked at $303K in Q2 2013.
  • 508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on World Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.